In previous studies published by our group, BGJ398, a potent and selective FGFR1–3 inhibitor, resulted in a prominent increase in apoptotic activity in IM-resistant GIST cells in vitro when used in combination with IM. Here, FGFR1 is linked to gastrointestinal stromal tumor.